UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2026
Commission File Number: 001-41411
Haleon plc
(Translation
of registrant’s name into English)
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
|
|
Form
20-F ☒
|
Form
40-F ☐
|
|
EXHIBIT INDEX
|
Exhibit Number
|
Description
|
|
99.1
|
13
March 2026 - “Publication of Annual Report 2025 & Notice
of AGM”
|
99.1
Haleon plc: Publication of Annual Report and Form 20-F 2025 and
Notice of 2026 AGM
13 March 2026: Haleon
plc (the "Company") announces that the following documents have
been published today and are available on its
website, www.haleon.com:
-
Annual Report and Accounts & Form 20-F 2025 (the 'Annual
Report'); and
-
Notice of 2026 Annual General Meeting ('AGM').
In addition, in accordance with Section 203.01 of the New York
Stock Exchange Listed Company Manual, the Annual Report & Form
20-F 2025 will also today be filed with the US Securities and
Exchange Commission and will shortly be available
at www.sec.gov.
Haleon's AGM will again be a virtual meeting taking place at 3.00pm
(BST) on Wednesday, 29 April 2026. The Notice of 2026 AGM is
available on the Company's website at https://www.haleon.com/investors/shareholder-information/annual-general-meetings,
and includes full details of the business to be conducted and
joining instructions.
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused
on better everyday health. Our people, our brands, our research,
our investment and our innovation are aimed at improving the
everyday health of consumers. Our product portfolio spans six major
categories - Oral Health, Vitamins, Minerals and Supplements (VMS),
Pain Relief, Respiratory Health, Digestive Health and Therapeutic
Skin Health and Other. Our superior brands - such
as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are trusted by more than one billion
consumers and are recommended by health professionals around the
world.
For more information, please visit www.haleon.com.
Notes
In compliance with the Disclosure Guidance and Transparency Rules,
the Annual Report, as submitted to the National Storage Mechanism,
contains regulated information in unedited full text and is
available on the Company's website as noted above.
In compliance with UK Listing Rules 6.4.1(R) and 6.4.3(R) copies of
the Annual Report, Notice of AGM, Form of Proxy for the 2026 AGM
and Voting Instruction Card have been submitted to the National
Storage Mechanism and will shortly be available for inspection
at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
Shareholders may request a free hard copy of the Annual Report,
including the complete audited financial statements of the Company.
Requests should be directed to [email protected].
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
HALEON PLC
(Registrant)
|
|
|
Date:
March 13, 2026
|
By:
|
/s/
Amanda Mellor
|
|
|
|
|
Name:
|
Amanda
Mellor
|
|
|
|
Title:
|
Company
Secretary
|